In recent months, many aspects of our society have been assaulted by significant changes to the regulations that protect our families from harmful chemicals in products and pollution in the environment.
A new bill that has passed the U.S. House of Representatives and is currently in the U.S. Senate would continue this assault.
H.R.5, the Regulatory Accountability Act of 2017, should raise many concerns about the impact of this bill. My interpretation of the provisions contained in H.R.5 leads me to group my concerns in three general areas.
H.R.5 would protect industry, not the public. I do not believe that the best regulatory option is the one that is best for industry. I believe the best regulatory option is the one that protects the health and well-being of my family. Rather than balancing the costs and benefits of health and safety protections, the Food and Drug Administration and other federal agencies would be required to choose the cheapest option that is available to industry.